VIVID-2: Mirikizumab (Omvoh) Shows Long-Term Efficacy for Crohn’s Disease
Findings from the VIVID-2 open-label extension study in patients with CD highlight long-term clinical and endoscopic outcomes with mirikizumab.
Findings from the VIVID-2 open-label extension study in patients with CD highlight long-term clinical and endoscopic outcomes with mirikizumab.
This noninferiority randomized clinical trial investigates whether administering tenofovir to pregnant individuals with hepatitis B virus beginning at gestational week 16 is noninferior to administering…
This randomized clinical trial evaluates the effect of a collaborative palliative care intervention compared to usual care among family members of patients in the intensive…
Amazon spent $26.3 billion in capital expenditures during the fourth quarter of 2024, and that is “reasonably representative” of what it plans to spend each…
Interim analysis of the Phase 3 FRONTIER3 trial found Mim8 well-tolerated in children with hemophilia A with and without inhibitors.
We’re drawn to stories. We understand the world through stories – both the narratives we read, and those we create and develop for ourselves. It’s…
An asymptomatic 17-year-old boy who had emigrated from El Salvador was found to have a pleural effusion on a chest radiograph. A small number of…
Researchers managed to create a low-cost AI reasoning model rivaling OpenAI’s in just 26 minutes, as outlined in a paper published last week. The model,…
You might not be familiar with Helium Mobile, but you should get acquainted with the company if you want to spend less on your phone…
Partnership is essential for solving complex global challenges. In global health, however, partnership has become associated with a specific model: public–private partnerships (PPPs), in which…
This cross-sectional study examines the association of lifetime cannabis use and recent cannabis use with brain function during cognitive tasks among young adults.